Patent Term Extension Application for OMISIRGE (omidubicel-onlv), Patent No. 7,955,852
🏛 Food and Drug Administration (FDA)FDA-2024-E-0223
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.